Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer

2 years ago

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™…

New Agreement with Municipality in Västmanland.

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / February 15, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ.) - hereby announces that our…

Topas Therapeutics Appoints Cristina de Min, M.D. as Chief Medical Officer

2 years ago

Dr. de Min brings over 25 years' experience in drug development in both big pharma and biotechShe will drive the…

Genuv Teams With Aiforia to Create an AI-Powered Version of its ATRIVIEW® Drug Screening Platform

2 years ago

ATRIVIEW® AI Platform Enables Faster and More Consistent Screening of Molecules That Demonstrate Neuroprotective and Neurogenerative Effects SEOUL, South Korea--(BUSINESS…

Biotricity Releases Fiscal 2022 Third Quarter Financial Results

2 years ago

Management to host investor call on Tuesday February 15th at 4:15 pm ET93% YOY Revenue Gains to $1.93 MillionRevenue Outpaces…

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year Ended December 31, 2021 and Provides Conference Call Information

2 years ago

Conference Call Scheduled for Tuesday, February 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / February 14, 2022 / Elite…

Boosh Clarifies Beanfields Release

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - February 14, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or…

LifeSpeak To Acquire Wellbeats – A U.S.-Based On-Demand B2B Physical Wellbeing Platform – for up to US$92.5 Million

2 years ago

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE…

Quantum-Si Announces Dr. Jonathan Rothberg as Interim CEO

2 years ago

Founder and Executive Chairman of the Board to Advance Quantum-Si’s Protein Sequencing Technology and Commercialization Strategy GUILFORD, Conn.--(BUSINESS WIRE)--Feb. 14,…

CompuMed, Inc. Announces Fiscal 2022 First Quarter Results

2 years ago

LOS ANGELES, CA / ACCESSWIRE / February 14, 2022 / CompuMed, Inc. (OTC PINK:CMPD) ("CompuMed" or the "Company") is pleased…